首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcyRIII and antibodies lacking core fucose
【24h】

Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcyRIII and antibodies lacking core fucose

机译:FcyRIII与缺乏核心岩藻糖的抗体之间的高亲和力结合需要独特的碳水化合物-碳水化合物相互作用

获取原文
获取原文并翻译 | 示例
       

摘要

Antibody-mediated cellular cytotoxicity (ADCC), a key immune effector mechanism, relies on the binding of antigen-antibody complexes to Fey receptors expressed on immune cells. Antibodies lacking core fucosylation show a large increase in affinity for FcγRIIIa leading to an improved receptor-mediated effector function. Although afucosylated IgGs exist naturally, a next generation of recombinant therapeutic, glycoenginereed antibodies is currently being developed to exploit this finding. In this study, the crystal structures of a glycosylated Fcγ receptor complexed with either afucosylated or fucosylated Fc were determined allowing a detailed, molecular understanding of the regulatory role of Fc-oligosaccharide core fucosylation in improving ADCC. The structures reveal a unique type of interface consisting of carbohydrate-carbohydrate interactions between glycans of the receptor and the afucosylated Fc. In contrast, in the complex structure with fucosylated Fc, these contacts are weakened or nonexistent, explaining the decreased affinity for the receptor. These findings allow us to understand the higher efficacy of therapeutic antibodies lacking the core fucose and also suggest a unique mechanism by which the immune system can regulate antibody-mediated effector functions.
机译:抗体介导的细胞毒性(ADCC)是一种关键的免疫效应机制,它依赖于抗原抗体复合物与免疫细胞上表达的Fey受体的结合。缺乏核心岩藻糖基化的抗体显示出对FcγRIIIa的亲和力大大增加,从而导致受体介导的效应子功能得到改善。尽管无岩藻糖基化的IgG自然存在,但目前正在开发下一代重组的,经糖工程改造的治疗性抗体,以利用这一发现。在这项研究中,确定了糖基化的Fcγ受体与岩藻糖基化或岩藻糖基化的Fc络合的晶体结构,从而可以对Fc-寡糖核心岩藻糖基化在改善ADCC中的调节作用进行详细的分子理解。该结构揭示了一种独特的界面类型,该界面类型由受体的聚糖和岩藻糖基化的Fc之间的碳水化合物-碳水化合物相互作用组成。相反,在具有岩藻糖基化的Fc的复杂结构中,这些接触减弱或不存在,这说明对受体的亲和力降低。这些发现使我们能够理解缺乏核心岩藻糖的治疗性抗体的更高功效,并提出了一种独特的机制,免疫系统可以通过该机制调节抗体介导的效应子功能。

著录项

  • 来源
  • 作者单位

    Pharma Research and Early Development, Roche Glycart AG, CH-8952 Schlieren, Switzerland;

    Pharma Research and Early Development, Roche Glycart AG, CH-8952 Schlieren, Switzerland;

    Pharma Research and Early Development, Roche Glycart AG, CH-8952 Schlieren, Switzerland;

    Pharma Research and Early Development, Roche Glycart AG, CH-8952 Schlieren, Switzerland;

    Pharma Research and Early Development, Roche Glycart AG, CH-8952 Schlieren, Switzerland;

    Pharma Research and Early Development, Roche Glycart AG, CH-8952 Schlieren, Switzerland;

    F. Hoffmann-La Roche AG, Pharma Research and Early Development, Discovery Technologies Basel, CH-4070 Basel, Switzerland;

    F. Hoffmann-La Roche AG, Pharma Research and Early Development, Discovery Technologies Basel, CH-4070 Basel, Switzerland;

    F. Hoffmann-La Roche AG, Pharma Research and Early Development, Discovery Technologies Basel, CH-4070 Basel, Switzerland;

    F. Hoffmann-La Roche AG, Pharma Research and Early Development, Discovery Technologies Basel, CH-4070 Basel, Switzerland;

    Pharma Research and Early Development, Roche Glycart AG, CH-8952 Schlieren, Switzerland;

    F. Hoffmann-La Roche AG, Pharma Research and Early Development, Discovery Technologies Basel, CH-4070 Basel, Switzerland;

  • 收录信息 美国《科学引文索引》(SCI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    immunoglobulin; afucosylation; antibody effector function; x-ray crystallography;

    机译:免疫球蛋白;岩藻糖基化;抗体效应子功能;X射线晶体学;
  • 入库时间 2022-08-18 00:40:56

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号